Bosh sahifaMDG1 • SWX
add
MediGene
Yopilish kursi
8,76 CHF
Yillik diapazon
8,76 CHF - 17,51 CHF
Bozor kapitalizatsiyasi
16,95 mln EUR
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,46 mln | -6,00% |
Joriy xarajat | 5,22 mln | -0,04% |
Sof foyda | -4,08 mln | -0,57% |
Sof foyda marjasi | -280,10 | -6,99% |
Har bir ulushga tushum | — | — |
EBITDA | -3,75 mln | 0,95% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 14,02 mln | -42,88% |
Jami aktivlari | 28,81 mln | -31,69% |
Jami passivlari | 9,15 mln | -23,69% |
Umumiy kapital | 19,66 mln | — |
Tarqatilgan aksiyalar | 14,74 mln | — |
Narxi/balansdagi bahosi | 6,58 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | -44,32% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -4,08 mln | -0,57% |
Operatsiyalardan naqd pul | -3,54 mln | 11,77% |
Sarmoyadan naqd pul | 3,85 mln | 201,29% |
Moliyadan naqd pul | 2,36 mln | 2 998,77% |
Naqd pulning sof oʻzgarishi | 2,68 mln | 194,29% |
Boʻsh pul | — | — |
Haqida
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia
Tashkil etilgan
1994
Bosh ofis
Sayt
Xodimlar soni
87
